Blueprint Medicines gains on Sanofi's $9 bln buyout offer
02/06/2025 10:12
** Blueprint Medicines BPMC.O jumps 27.03% to $128.74 premarket ** French drugmaker Sanofi SASY.PA to buy Blueprint for more than $9 billion ** Sanofi paying $129/share in cash for Blueprint, a 27% premium to last close ** Deal's equity value ~$9.1 billion, with potential to increase to $9.5 billion, including contingent value rights ** Acquisition expected to be finalized in Q3 2025 ** BPMC up 16.2% this year, as of last close (Reporting by Sriparna Roy in Bengaluru) ((Sriparna.Roy@thomsonreuters.com;))
Recent news on Blueprint Medicines
See all newsBrief: Sanofi Announces Extension Of Blueprint Tender Offer
Brief: Blueprint Medicines Announces Data Reinforcing Safety Profile Of Long-Term Ayvakit
U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, Circle
UBS raises Blueprint Medicines' PT on Sanofi's up to $9.5 billion takeover deal
U.S. RESEARCH ROUNDUP-Biomea Fusion, GE Aerospace, P&G